Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Spot Gold scaled a fresh all-time high of $3,086.09 per troy ounce on Friday, as US President Trump’s tariff plans sparked concerns of an expanding global trade war, triggering a rush to safe haven assets.

Trump on Wednesday announced a 25% tariff on imported cars and light trucks, which followed earlier measures, including levies on steel and aluminum imports.

Canada’s Prime Minister Mark Carney said yesterday his country would respond with unspecified trade actions in case the US imposes new auto tariffs.

The European Union has also threatened to implement retaliatory tariffs.

The Trump administration’s reciprocal tariffs, which are set to take effect on April 2nd, now come in the spotlight, as many believe they may reignite inflation and hinder GDP growth.

“Gold has the wind at its back at the moment. U.S. trade policy, U.S. fiscal policy, geopolitics, and a growth slowdown – everything is blowing in gold’s direction,” Capital.com’s financial market analyst Kyle Rodda was quoted as saying by Reuters.

Uncertainty surrounding US tariffs, potential rate cuts, geopolitical conflicts and sustained central bank buying have fueled Gold’s rally to a series of record highs this year.

Spot Gold was last up 0.46% on the day to trade at $3,070.72 per troy ounce.

Spot Gold scales a fresh all-time high of $3,086.09 per troy ounce.

In terms of macro data, traders are now expecting the US PCE inflation report, which may provide more insight into the Federal Reserve’s potential course of action in regard to interest rates.

Annual PCE inflation probably remained steady at 2.5% in February, according to market consensus, while annual core PCE inflation probably picked up to 2.7%.

The data will be particularly relevant after the Federal Reserve’s recent upward revision of its annual core PCE inflation forecast.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • British pound on session high, US dollar struggles for positionsBritish pound on session high, US dollar struggles for positions On Wednesday US dollar showed retreat against its major peers, while British pound recorded a session high against the greenback.GBP/USD hit 1.5130 during late European session, after which consolidated at 1.5110-1.5115. Support was […]
  • Spot Gold holds below $3,350 ahead of key macro dataSpot Gold holds below $3,350 ahead of key macro data Spot Gold edged lower on Tuesday, holding below the $3,350 mark, as market players continued to pay attention to tariff negotiations at the start of a data-laden week.US Treasury Secretary Scott Bessent said yesterday that many key US […]
  • Forex Market: NZD/USD forecast for MondayForex Market: NZD/USD forecast for Monday During Friday’s trading session NZD/USD traded within the range of 0.8531-0.8574 and closed at 0.8553, losing 0.15% for the day and 0.94% for the week.Fundamental viewNew ZealandThe surplus on New Zealands trade balance probably […]
  • WTI crude near two-week lowWTI crude near two-week low WTI crude fell for a fifth day near a two-week low amid low demand and increased stockpiles. The Energy Information Administrations oil reserves report is scheduled for release in the morning. The industry-funded American Petroleum Institute […]
  • Forex Market: GBP/NZD daily forecastForex Market: GBP/NZD daily forecast During yesterday’s trading session GBP/NZD traded within the range of 1.9647-1.9767 and closed at 1.9729.At 7:55 GMT today GBP/NZD was losing 0.01% for the day to trade at 1.9708. The pair touched a daily low at 1.9669 at 5:10 […]
  • Pfizer Inc. share price, increases its bid for AstraZeneca to 106.5 billion dollars to create the world’s largest pharmaceutical companyPfizer Inc. share price, increases its bid for AstraZeneca to 106.5 billion dollars to create the world’s largest pharmaceutical company Pfizer Inc. made an official statement, revealing that it increased its offer for the second-largest drug manufacturer in the U.K. - AstraZeneca Plc to about 63.1 billion pounds (106.5 billion dollars) in an attempt to lure the latter with the […]